{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:15:46Z","timestamp":1792293346678,"version":"4.4.0"},"reference-count":29,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Form Res"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Psychedelic substances have demonstrated promise in the treatment of depression, anxiety, and substance use disorders. Significant media coverage has been dedicated to psychedelic medicine, but it is unclear whether the public associates psilocybin with its potential therapeutic benefits. The COVID-19 pandemic led to an increase in depression, anxiety, and substance abuse in the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study attempts to link increases in interest in these disorders with increases in interest in psilocybin using Google Trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Weekly interest-over-time Google Trends data for 4 years, from the week of March 11, 2018, to the week of March 6, 2022, were obtained for the following terms: \u201cpsilocybin,\u201d \u201cpsychedelic therapy,\u201d \u201ccannabis,\u201d \u201ccocaine,\u201d \u201cantidepressant,\u201d \u201cdepression,\u201d \u201canxiety,\u201d and \u201caddiction.\u201d Important psilocybin-related news and the declaration of the pandemic were noted. Trends data for each of the queried terms were plotted, and multiple regression analysis was performed to determine the slope of the prepandemic and postpandemic data with 95% CIs. Nonparametric Tau-U analysis was performed correcting for baseline trends. Results from this test were used to make inferences about the pre- and postpandemic trends and inferences about the change in overall level of searches between the 2 groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Tau values for prepandemic data were significant for stable trends, all ranging \u20130.4 to 0.4. Tau values for postpandemic data showed positive trends for \u201cpsilocybin,\u201d \u201cpsychedelic therapy,\u201d and \u201cantidepressant.\u201d All other trends remained stable in the range of \u20130.4 to 0.4. When comparing Tau values for pre- and postpandemic data, overall increases in relative search volume (RSV) were seen for \u201cpsilocybin,\u201d \u201cpsychedelic therapy,\u201d and \u201canxiety,\u201d and overall decreases in RSV were seen for \u201cdepression,\u201d \u201caddiction,\u201d and \u201ccocaine.\u201d Overall RSVs for \u201ccannabis\u201d and \u201cantidepressant\u201d remained stable as Tau values ranged between \u20130.4 and 0.4. In the immediate aftermath of the declaration of the pandemic, drop-offs in interest were seen for all terms except for \u201canxiety\u201d and \u201ccannabis.\u201d After the initial shock of a global pandemic, \u201cpsilocybin\u201d and \u201cpsychedelic therapy\u201d groups demonstrated increases in interest trends and overall RSV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These data suggest that overall interest in \u201cpsilocybin\u201d and \u201cpsychedelic therapy\u201d increased at higher rates and to higher levels after than before the declaration of the pandemic. This is consistent with our hypothesis that interest increased for these treatments after the pandemic as incidence of depression, anxiety, and addiction increased. However, there may be other drivers of interest for these topics, since interest in antidepressants\u2014the typical pharmacologic treatments for depression and anxiety\u2014followed the expected pattern of drop-off and accelerated interest back to prepandemic levels. Interest in \u201cpsilocybin\u201d and \u201cpsychedelic therapy\u201d may have also been partially driven by popular culture hype and novelty, explaining why interest increased at a higher rate post pandemic and continued to grow, surpassing prior interest.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/43850","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T07:05:01Z","timestamp":1701155101000},"page":"e43850","source":"Crossref","is-referenced-by-count":15,"title":["Public Interest in Psilocybin and Psychedelic Therapy in the Context of the COVID-19 Pandemic: Google Trends Analysis"],"prefix":"10.2196","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2111-4827","authenticated-orcid":false,"given":"George","family":"Danias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3523-9145","authenticated-orcid":false,"given":"Jacob","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1310-3990"},{"key":"ref2","unstructured":"Delic Holdings IncSurvey Finds Majority of Affected Americans Approve of Psychedelics as an Alternative Treatment to Address Anxiety, Depression and PTSDCision US Inc20222022-01-18http:\/\/tinyurl.com\/3mnstxs8"},{"key":"ref3","unstructured":"Johns Hopkins Launches Center For Psychedelic ResearchJohns Hopkins Medicine20192023-12-12http:\/\/tinyurl.com\/yxh2amcf"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26102948"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.112749"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00955"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.2096"},{"key":"ref8","unstructured":"Coronavirus in the U.S.: Latest Map and Case CountThe New York Times2020-03-03https:\/\/www.nytimes.com\/interactive\/2021\/us\/covid-cases.html"},{"key":"ref9","unstructured":"InadaMJapan Has Fewest Covid-19 Deaths Per Capita in OECD, New Data ShowThe Wall Street Journal20222023-12-12http:\/\/tinyurl.com\/mu7me4kb"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.17223"},{"key":"ref11","unstructured":"ReinertMFritzeDNguyenTThe State of Mental Health in America 2022Mental Health America20212023-12-12http:\/\/tinyurl.com\/3atbbymp"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109150"},{"key":"ref13","unstructured":"Google Trends2023-08-24https:\/\/trends.google.com\/trends\/"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2196\/13439"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ttbdis.2019.101306"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.03.019"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.22540\/jfsf-06-032"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1037\/tra0000872"},{"key":"ref19","unstructured":"The New York Times2023-08-24https:\/\/www.nytimes.com\/"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4135\/9781544391199"},{"key":"ref21","unstructured":"Microsoft Excel2023-12-12https:\/\/office.microsoft.com\/excel"},{"key":"ref22","unstructured":"NCSS Statistical Software2023-12-12https:\/\/www.ncss.com\/software\/ncss\/"},{"key":"ref23","unstructured":"VannestKJ, Parker, R.I., Gonen, O., & Adiguzel, T. Single Case Research: web based calculators for SCR analysis. (Version 2.0) Web-based application. College Station, TX: Texas A&M University. Retrieved Saturday 11th November 2023.singlecaseresearch.org20162023-11-10https:\/\/singlecaseresearch.org"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/23311908.2018.1518687"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000566"},{"key":"ref26","unstructured":"Percentage of adolescents reporting drug use decreased significantly in 2021 as the COVID-19 pandemic enduredNational Institute on Drug Abuse20212023-11-14http:\/\/tinyurl.com\/mr2djb6z"},{"key":"ref27","unstructured":"AhmadFBCisewskiJARossenLMSuttonPProvisional drug overdose death countsNational Center for Health Statistics20232023-12-12https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-0790-0"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10813-9"}],"container-title":["JMIR Formative Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/formative.jmir.org\/2023\/1\/e43850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:46:50Z","timestamp":1782841610000},"score":1,"resource":{"primary":{"URL":"https:\/\/formative.jmir.org\/2023\/1\/e43850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":29,"URL":"https:\/\/doi.org\/10.2196\/43850","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.43850","asserted-by":"object"}]},"ISSN":["2561-326X"],"issn-type":[{"value":"2561-326X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,29]]}}}